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Abstract
A graphite-paste tyrosinase biosensor was improved by adding 1-methoxyphenazine methosulfate as a
mediator. Mediator modification enhanced sensitivity to phenol 4-fold and long-term stability 3-fold.
Phenol could be detected at 25 nM (S/N=2) using an Ag/AgCl reference electrode. The biosensor was used
to measure the activity of a toxicologically significant enzyme, neuropathy target esterase (NTE), which
yields phenol by hydrolysis of the substrate, phenyl valerate. Using the new biosensor, blood and brain
NTE inhibition by organophosphorus (OP) compounds with different neuropathic potencies were well
correlated (r=0.990, n=7), supporting the use of blood NTE as a biochemical marker of exposure to
neuropathic OP compounds.
Introduction
Tyrosinase biosensors can detect phenol electro-
chemically at sub-nanomolar levels (Kotte et al.
1995, Shan et al. 2002, Wang et al. 2002).
Accordingly, such electrodes are widely used,
mainly for detection of phenols as environmental
pollutants. Phenolic biosensors can also monitor
enzymatic processes that yield phenols.
Tyrosinase biosensors have been used for
electrochemical analysis of a toxicologically sig-
nificant enzyme, neuropathy target esterase
(NTE) (Sigolaeva et al. 1999, 2001, Makhaeva
et al. 2003). NTE hydrolyzes the substrate, phe-
nyl valerate, to produce phenol. Inhibition of
NTE by neuropathic organophosphorus (OP)
compounds initiates OP compound-induced de-
layed neurotoxicity (OPIDN) (Johnson 1982,
Glynn 1999, Huggins & Richardson 1999). Inhi-
bition of brain NTE within hours of exposure
to a neuropathic OP compound predicts the on-
set of OPIDN in adult hens 1–3 weeks later
(Johnson 1982, 1990, Lotti 1986, Richardson
1995, 1998). Tyrosinase biosensors enable NTE
to be assayed in whole blood, which cannot be
done with the standard colorimetric method (Si-
golaeva et al. 2001). The original tyrosinase car-
bon-paste biosensor was used to establish
correlations of NTE inhibition in blood with
that in lymphocytes and brain 24 h after dosing
hens with a neuropathic OP compound, O,O-di-
1-propyl O-2,2-dichlorvinyl phosphate. These
studies demonstrated that the biosensor NTE as-
say for whole blood could serve as a biomarker
of exposure to neuropathic OP compounds
(Makhaeva et al. 2003).
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The present report describes the preparation
of a 1-methoxyphenazine methosulfate (MPMS)-
modified tyrosinase carbon-paste electrode for
improved electrochemical analysis of NTE activ-
ity in blood for the enhancement of biomonitor-
ing exposures to neuropathic OP compounds.
Materials and methods
Chemicals
Mushroom tyrosinase (monophenol monooxi-
dase, EC 1.14.18.1), activity 3800 U/mg for L-
tyrosine, graphite powder, phenol, MPMS, and
Paraoxon (O,O-diethyl-4-nitrophenyl phosphate)
were purchased from Sigma. Phenyl valerate was
from Oryza (Chelmsford, USA). N,N¢-di-2-
propylphosphorodiamido fluoridate (Mipafox),
O,O-diethyl O-2,2-dichlorovinylphosphate, O,O-
di-1-propyl O-2,2-dichlorovinylphosphate and the
O-alkyl-O-methylchloroformimino phenylphosph-
onate compounds [(RO)C6H5P(O)ON=CClCH3
(R=alkyl)] were synthesized and characterized in
the Institute of Physiologically Active Com-
pounds, Russian Academy of Sciences (RAS)
(Russia). All other chemicals were of analytical
grade and used without further purification.
Aqueous solutions were prepared using deionized
water.
Preparation of tyrosinase electrode and assembly
of biosensor
The tyrosinase electrode was prepared as de-
scribed below. Graphite/paraffin oil (3.5:1, w/w)
were mixed thoroughly and packed firmly into a
plastic holder (2 mm diameter). Electrical contact
was established by a 0.2-mm copper wire inserted
from the rear. The surface of the electrode was
covered by the composite of tyrosinase, graphite,
MPMS, and paraffin oil (2:5.6:1:2, by weight),
and then the surface was polished. The electrodes
were stored dry at 4 C until use. In experiments
with optimization of tyrosinase concentration in
carbon composite, tyrosinase, graphite, MPMS,
and paraffin oil were [x:(7.6)x):1:2, by weight].
The enzyme amount (x) was varied from 0.2 to
2 mg. The components ratio of [2:(6.6)y):y:2, by
weight] was used for optimization of MPMS con-
centration. MPMS amount (y) was in the range
of 0.2–1.4 mg.
Electrochemical measurements
All measurements were performed with an IPC-
2000 potentiostat (Institute of Physical Chemis-
try, RAS). The amperometric current response
was recorded at )150 mV vs. the Ag/AgCl refer-
ence electrode in a flow-through electrochemical
cell after an injection of the samples into a flow
of sodium phosphate buffer with 0.1 M NaCl,
via an injector with a 50 ll sample loop (Valve
V-7, Pharmacia, Sweden) at a flow rate of
0.25 ml/min. Each measurement was made in
triplicate.
The cyclic voltammograms of the electrodes
were performed in a 1 ml electrochemical cell
with stirring in the o-quinone redox potential
range. In all cases, a third cyclic voltammogram
was used for calculations.
Hen brain NTE assay
A lyophilized hen brain membrane fraction con-
sisting of combined mitochondrial/synaptosomal
and microsomal pellets (P2+P3) (Richardson
et al. 1979) preinhibited with paraoxon (40 lM at
25 C for 45 min) was used as a source of NTE.
It was prepared as described (Makhaeva &
Malygin 1999) and stored in sealed ampoules.
Before use, ampoule contents were suspended
with a Potter homogenizer in 5 ml of working
buffer (50 mM Tris/HCl, 0.2 mM EDTA, pH 8.0
at 25 C).
NTE activity was determined colorimetrically
according to the differential inhibition method of
Johnson (1977) as modified by Kayyali et al.
(1991) at 492 nm using a Benchmark Plus Micro-
plate Reader (Bio-Rad, USA). Each measure-
ment was made in triplicate. Protein was
determined by the microbiuret method with bo-
vine serum albumin as a reference standard.
Whole blood NTE assay
Whole hen blood stabilized by citrate/EDTA was
diluted 10-fold with working buffer and homoge-
nized in a Potter glass/glass homogenizer before
NTE assay. The differential inhibition method of
Johnson (1977) with an electrochemical endpoint
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was used as described in (Makhaeva et al. 2003).
Each measurement was made in triplicate.
Protein was determined using a Coomassie
protein assay kit from Sigma (USA) with bovine
serum albumin as a reference standard.
NTE I50 determinations
The I50 (the concentration that inhibits 50% of
the enzyme activity under defined preincubation
conditions) for inhibitors against NTE was mea-
sured by preincubating a sample of enzyme with
10–12 different concentrations of the OP com-
pound for 20 min at 37 C, in working buffer.
Residual NTE activity was then determined
either using the colorimetric (brain NTE) or the
amperometric (blood NTE, the MPMS-modified
tyrosinase carbon-paste electrode) method. Each
measurement was made in triplicate (colorime-
try) or in duplicate (amperometry). I50 values
were calculated using Origin 6.1 software
(Northampton, MA, USA). Every value repre-
sents the mean±SEM from three independent
experiments.
Results and discussion
Mediator-modified tyrosinase carbon paste
electrode
The tyrosinase carbon paste electrode involves
oxidation of phenol via catechol into o-quinone
by the tyrosinase. Then o-quinone is electrochem-
ically reduced to catechol directly at the electrode
when the required potential is applied. However,
regeneration via mediator gives an increased sen-
sitivity to phenol compared to the direct electro-
reduction of o-quinone (Figure 1).
We used MPMS as a light-stable mediator for
the tyrosinase sensor modification. Various as-
pects concerning the electrode construction and
operation have been studied and optimized as de-
tailed below.
Cyclic voltammetry
Figure 2 shows the cyclic voltammograms of the
mediator-modified tyrosinase electrode in 10 lM
phenol solution at various potential scan rates in
the range between 2 and 40 mV/s.
Both the oxidation and reduction potential
values depended upon the scan rate. In addition,
the cathodic and anodic peak currents coincided,
and the nonlinearity depended upon the square
root of the potential scan rate (data not shown).
Thus, the redox system considered represents
quasi-reversible character, and the polymeric
quinoid products that can irreversibly bind and
poison the electrode surface apparently do not
readily form.
Fig. 1. Principle of amperometric phenol detection by 1-meth-
oxyphenazine methosulfate (MPMS)-modified tyrosinase car-
bon-paste electrode.
Fig. 2. Cyclic voltammograms of the 1-methoxyphenazine
methosulfate (MPMS)-modified electrode at various potential
scan rates. Conditions: tyrosinase and MPMS contents in car-
bon paste were 2 mg and 1 mg, respectively; 0.05 M phos-
phate buffer solution with 0.1 M NaCl; pH 7.0; 10 lM phenol.
The potential scan rates were (a) 2, (b) 5, (c) 10, (d) 20 and
(e) 40 mV/s vs. Ag/AgCl.
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Optimization of carbon paste composite
The influence of tyrosinase and mediator concen-
trations in the carbon composite on analytical
properties of the modified electrodes was studied
by screening electrode response to the addition of
standard phenol solution. The electrodes were
prepared as described above. The maximum re-
sponse was achieved with 2 mg tyrosinase. Fur-
ther increasing enzyme content resulted in
deterioration of the physical properties of the
carbon composite resulting in peeling off the ac-
tive paste layer from the electrode surface. The
effect of MPMS concentration in the carbon
composite on the electrode response was assessed
between 0.2 and 1.4 mg MPMS. The electrodes
were prepared as described above. The electrode
response was found to increase to a plateau at
0.6 mg of the mediator content. Thus, a signal
gain of more than four times was achieved in
comparison with the unmodified electrode.
Optimization of measuring conditions
The effect of operating potential on the media-
tor-modified electrode response was examined in
the range between )25 and )250 mV vs. Ag/
AgCl in comparison with the unmodified elec-
trode. As seen in Figure 3, the highest signals are
obtained at potential values between )175 and
)200 mV for both electrode types. Nevertheless,
the recommended optimal operating potential is
)150 mV, because the background current signif-
icantly decreases in that case, while the electrode
responses remain high. Furthermore, the rela-
tively low operating potential decreases the influ-
ence of interfering electrochemical reactions on
selectivity and sensitivity of the assay.
The influence of pH was studied from 4.5 to
9.5. The addition of the mediator to the carbon
paste composite did not shift the pH optimum of
immobilized tyrosinase (Duckworth & Coleman
1970), which remained at pH 7.0.
Figure 4 shows the influence of ionic strength
on the character of response of both the media-
tor-modified and unmodified electrodes to 10 lM
phenol. The response of the unmodified electrode
increased with rising NaCl concentration up to
0.05 M. Further increases in ionic strength of
the buffer solution had no effect on electrode
response. The mediator-modified electrode
response increased with rising NaCl concentra-
tion up to 0.35 M, and exhibited about a two-fold
increase in electrode response in a comparison
Fig. 3. Effect of the operating potential on the response cur-
rent of 1-methoxyphenazine methosulfate (MPMS)-modified
(a) and unmodified (b) electrodes. Conditions: 0.05 M phos-
phate buffer solution with 0.1 M NaCl; pH 7.0; 10 lM phenol.
Fig. 4. Influence of NaCl concentration on the response of 1-
methoxyphenazine methosulfate (MPMS)-modified (a) and
unmodified (b) electrodes. Conditions: 0.05 M phosphate buf-
fer solution containing (0 to 0.35 M) NaCl, pH 7.0; 10 lM
phenol.
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with standard conditions of measurements at
0.1 M NaCl.
Analytical characteristics of MPMS-modified
tyrosinase carbon paste electrodes
The dependence of the MPMS-modified electrode
responses on a wide range of phenol concentra-
tion is shown in Figure 5. The response was lin-
ear up to 50 lM. The detection limit of 25 nM (S/
N=2) was reached for the mediator-modified
electrode, while the detection limit of the unmod-
ified electrode was 100 nM.
The operational stability of MPMS-modified
electrodes was examined by serial measurements
of 100 lM phenol. After 80 measurements, the
electrode retained its initial activity with a coeffi-
cient of variation of less than 3%.
The results on functional stability are shown
in Figure 6. Data were obtained for electrodes
used in the flow-injection system at room temper-
ature during the day and stored overnight at
4 C in the working buffer solution. The unmodi-
fied electrode lost about 80% of its initial activity
after 9 days. In contrast, the response of the
MPMS-modified electrode decreased 23% after
9 days and 37% after 15 days. In the dry state at
4 C, the electrodes keep their initial activity for
more than 12 months.
The main analytical characteristics of MPMS-
modified electrodes are summarized in Table 1.
Whole blood NTE analysis as a biomarker
of neuropathic OP compound exposure
We previously showed that the tyrosinase carbon-
paste electrode remarkably improved the sensitiv-
ity of the NTE assay in comparison with a colori-
metric method (Sigolaeva et al. 2001). Due to the
high sensitivity of the biosensor method, the influ-
ence of interfering blood components (ascorbic
acid, tyrosine, and others) was reduced by the high
extent of sample dilution, thus allowing NTE to
be detected selectively and with high sensitivity in
whole blood, for which the usual colorimetric
Fig. 5. Calibration curve of phenol at the methoxyphenazine
methosulfate (MPMS)-modified electrode. Conditions: 0.05 M
phosphate buffer solution with 0.1 M NaCl; pH 7.0; applied
working potential )150 mV vs. Ag/AgCl.
Fig. 6. Storage stability of the 1-methoxyphenazine methosul-
fate (MPMS)-modified (a) and unmodified (b) electrodes in
0.05 M phosphate buffer solution with 0.1 M NaCl; pH 7.0;
4 C. Relative electrode response values (ordinate axis) repre-
sent the electrode response obtained in a period from 1 to
15 days of storage against the initial electrode response
obtained on the first experimental day.
Table 1. Characteristics of the phenol biosensor based on 1-
methoxyphenazine methosulfate (MPMS)-modified tyrosinase
carbon paste electrode.
Analytical parameter Value
Linear range 0.025–50 lM
Detection limit of phenol (S/N=2) 25 nM
Sample volume 50 ll
Time of analysis 2 min
Work stability >60 % during 21 days
Storage stability (dry) >12 months
Coefficient of variation of
electrode preparation
25%




























































aControl NTE activities, nmol/(min·mg protein), mean±SEM, n=3. Lyophilized preparation of hen brain NTE=41±2, whole
blood=0.23±0.02.
bI50 was determined using the unmodified tyrosinase carbon-paste electrode.
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assay is impossible. Using the unmodified elec-
trode, whole blood samples could be diluted 1:500
(v/v). Dilution of 1:1400 (v/v) was achieved with
the MPMS-modified electrode.
Blood NTE activity measurements with the
new MPMS-modified tyrosinase carbon-paste
electrode were explored as a possible biochemical
marker of neuropathic OP compound exposures.
The biosensor assay was used to obtain I50 val-
ues for inhibition of blood NTE activity in vitro
with a number of standard neuropathic OP com-
pounds. These include mipafox, O,O-diethyl- and
O,O-di-1-propyl O-dichlorovinyl phosphates, as
well as a series of O-alkylphenyl phosphonates of
general formula RO(C6H5)P(O)ON=CCH3Cl
where R=Me, Et, n-Pr, n-Bu. The neuropathic
potential in the last series of compounds was
shown to increase with R-group length (Makha-
eva et al. 2001, Malygin et al. 2003). The stan-
dard colorimetric assay was used to determine
the I50 for these compounds against a prepara-
tion of hen brain NTE. The data presented in
Table 2 show that all inhibitors exhibited a simi-
lar inhibitory potency in vitro toward NTE from
hen brain and hen blood. NTE from both sour-
ces had the same sensitivity to variations in
structure and neuropathic potential of OP inhibi-
tors. A good correlation was found between the
values of pI50 for blood and brain NTE inhibi-
tion by the studied compounds (r=0.990, n=7).
Furthermore, consistent agreement was obtained
between two amperometric methods (MPMS-
modified and unmodified electrodes) for I50
determinations of mipafox and O,O-di-1-propyl
O-dichlorovinyl phosphate against blood NTE.
The data support the validity of measurements
carried out with the new MPMS-modified tyrosi-
nase carbon paste biosensor and demonstrate
that blood NTE inhibition is a promising
biomarker of exposure to neuropathic OP
compounds.
NTE Analyzer
A pilot device (Analyzer) incorporating the new
biosensor for NTE assays was developed. The
Analyzer consists of an internal microprocessor,
flow-through electrochemical cell supplied with
working and reference electrodes, pump, sampler,
vessels for working buffer and waste, liquid
crystal display, and controls for manual opera-
tion. All functions are controlled and monitored
by an external computer. The software provides
measurement monitoring, and displays the mea-
sured signal in real-time format. Data processing
is also possible.
The application of this device is expected to
facilitate the rapid assessment of human expo-
sures to neuropathic OP compounds that could
arise through occupational, environmental, or
accidental means, or from warfare or terrorist
acts.
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